entertainment -WSS

entertainment

author：fashion 2025-09-05 05:49:40 - browse：14

George Yancopoulos on the 2024 Breakthrough Summit East stage. — George Yancopoulos on the 2024 Breakthrough Summit East stage STAT

George Yancopoulos is in touch with his teenage self.

After 35 years as head scientist at Regeneron Pharmaceuticals, Yancopoulos has led the development of 12 approved medicines, turning a once-fledgling company into the $100 billion global drugmaker it is today. And you can trace a straight line back to the childhood fascination with science he fostered growing up in Woodside, Queens.

“My high school science project was about regenerating neurons, and ‘Regeneron’ is a contraction of ‘regenerating neurons,’” Yancopoulos said at the STAT Summit East on Thursday. “In some ways I’m still working on my high school science project.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Senators tussle over abortion against the backdrop of a presidential campaign

WSS

Eli Lilly’s Zepbound improved liver scarring in mid

STAT wants to know your pick for a great summer read or listen

UnitedHealth CEO's Medicaid comments send insurer stocks diving

Longer MASH drug regimen improved liver, Akero study finds

Take antibiotics after sex, CDC recommends for certain risk groups

'Little Tech' descents on D.C., wanting a say in how AI is regulated

focus

entertainment

hotspot

Hollywood unions extend contract negotiations for actors

A new initiative will help leaders fight the next pandemic

BioMarin wins approval for gene therapy to treat hemophilia A

The untold story of TV’s first prescription drug ad

Novavax promises a turnaround & Lilly roils the obesity market

$1 billion proposal to grow Boston, Massachusetts biotech

Walensky prepares to leave CDC — and Congress — behind

Families look for replacement for GSK asthma drug Flovent

Hollywood unions extend contract negotiations for actors

Finland to offer bird flu vaccine to select groups of people, a possible global first

explore

IVF doctors demand details after CooperSurgical lawsuit

BD to buy Edwards patient monitoring unit for $4.2 billion

Senators tussle over abortion against the backdrop of a presidential campaign

Readout Newsletter: BridgeBio, Akero, and human embryo models

Finland to offer bird flu vaccine to select groups of people, a possible global first

For AI in health care standards, federal regulators join with industry group

explore

knowledge

hotspot

focus